FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1516911000001104: Tamofen 10 tablets (Pfizer Ltd) 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24255301000001116 Tamofen 10 tablets (Pfizer Ltd) 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
24255401000001112 Tamofen 10 tablets (Pfizer Ltd) 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Is a Tamoxifen 10mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Is pack of Tamofen 10 tablets (Pfizer Ltd) false Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Has active ingredient Tamoxifen citrate false Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Has active ingredient Tamoxifen false Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Has AMP Tamofen 10 tablets (Pfizer Ltd) true Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tamoxifen true Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Has specific active ingredient Tamoxifen citrate true Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Tamofen 10 tablets (Pfizer Ltd) 30 tablet Has basis of strength substance Tamoxifen true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start